Lung cancer incidence and mortality with extended follow-up in the National LungScreening Trial

The extended follow-up of the NLST represents a timely and important update to the NLST data, alongside full results of the NELSON and the LUSI trials, as Europe begins to set out a vision for lung cancer screening. http://bit.ly/2MYXedI

Detalles Bibliográficos
Autores principales: Frille, Armin, Hardavella, Georgia, Lee, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078741/
https://www.ncbi.nlm.nih.gov/pubmed/32194768
http://dx.doi.org/10.1183/20734735.0322-2019
_version_ 1783507683974840320
author Frille, Armin
Hardavella, Georgia
Lee, Richard
author_facet Frille, Armin
Hardavella, Georgia
Lee, Richard
author_sort Frille, Armin
collection PubMed
description The extended follow-up of the NLST represents a timely and important update to the NLST data, alongside full results of the NELSON and the LUSI trials, as Europe begins to set out a vision for lung cancer screening. http://bit.ly/2MYXedI
format Online
Article
Text
id pubmed-7078741
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-70787412020-03-19 Lung cancer incidence and mortality with extended follow-up in the National LungScreening Trial Frille, Armin Hardavella, Georgia Lee, Richard Breathe (Sheff) Expert Opinion The extended follow-up of the NLST represents a timely and important update to the NLST data, alongside full results of the NELSON and the LUSI trials, as Europe begins to set out a vision for lung cancer screening. http://bit.ly/2MYXedI European Respiratory Society 2020-03 /pmc/articles/PMC7078741/ /pubmed/32194768 http://dx.doi.org/10.1183/20734735.0322-2019 Text en Copyright ©ERS 2020 http://creativecommons.org/licenses/by-nc/4.0/Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Expert Opinion
Frille, Armin
Hardavella, Georgia
Lee, Richard
Lung cancer incidence and mortality with extended follow-up in the National LungScreening Trial
title Lung cancer incidence and mortality with extended follow-up in the National LungScreening Trial
title_full Lung cancer incidence and mortality with extended follow-up in the National LungScreening Trial
title_fullStr Lung cancer incidence and mortality with extended follow-up in the National LungScreening Trial
title_full_unstemmed Lung cancer incidence and mortality with extended follow-up in the National LungScreening Trial
title_short Lung cancer incidence and mortality with extended follow-up in the National LungScreening Trial
title_sort lung cancer incidence and mortality with extended follow-up in the national lungscreening trial
topic Expert Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078741/
https://www.ncbi.nlm.nih.gov/pubmed/32194768
http://dx.doi.org/10.1183/20734735.0322-2019
work_keys_str_mv AT frillearmin lungcancerincidenceandmortalitywithextendedfollowupinthenationallungscreeningtrial
AT hardavellageorgia lungcancerincidenceandmortalitywithextendedfollowupinthenationallungscreeningtrial
AT leerichard lungcancerincidenceandmortalitywithextendedfollowupinthenationallungscreeningtrial

Ejemplares similares